Insmed (INSM)
(Delayed Data from NSDQ)
$24.92 USD
-0.89 (-3.45%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $24.95 +0.03 (0.12%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -1.21 |
EPS Last Quarter | -1.28 |
Last EPS Surprise | -13.27% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.68 |
Next Year | -3.88 |
EPS (TTM) | -5.33 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 79.88M | 89.22M | 355.21M | 485.89M |
# of Estimates | 5 | 5 | 6 | 6 |
High Estimate | 85.37M | 90.52M | 358.98M | 601.06M |
Low Estimate | 77.03M | 87.07M | 350.10M | 422.99M |
Year ago Sales | 65.21M | 77.23M | 305.21M | 355.21M |
Year over Year Growth Est. | 22.49% | 15.53% | 16.38% | 36.79% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.21 | -1.18 | -4.68 | -3.88 |
# of Estimates | 7 | 5 | 9 | 8 |
Most Recent Consensus | -1.19 | -1.19 | -4.47 | -2.87 |
High Estimate | -1.11 | -1.07 | -4.34 | -2.87 |
Low Estimate | -1.31 | -1.42 | -5.20 | -5.16 |
Year ago EPS | -1.17 | -1.78 | -5.34 | -4.68 |
Year over Year Growth Est. | -3.42% | 33.71% | 12.36% | 17.22% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 3 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.21 | -1.18 | -4.68 | -3.88 |
7 Days Ago | -1.21 | -1.18 | -4.65 | -3.81 |
30 Days Ago | -1.21 | -1.18 | -4.65 | -3.81 |
60 Days Ago | -1.22 | -1.16 | -4.59 | -3.74 |
90 Days Ago | -1.14 | -1.18 | -4.52 | -3.59 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.21 | -1.18 | -4.94 | -4.32 |
Zacks Consensus Estimate | -1.21 | -1.18 | -4.68 | -3.88 |
Earnings ESP | 0.00% | 0.00% | -5.51% | -11.45% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.28 | -1.10 | -1.78 | -1.17 | NA |
Estimate | -1.13 | -1.06 | -1.10 | -1.08 | NA |
Difference | -0.15 | -0.04 | -0.68 | -0.09 | -0.24 |
Surprise | -13.27% | -3.77% | -61.82% | -8.33% | -21.80% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more